Loading...
NPI 1831195965 · Providence, RI · Retina Specialist (Ophthalmology) Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Robert Janigian is a retina specialist (ophthalmology) physician provider located in Providence, Rhode Island. This profile covers 13 Medicare and 5 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Robert Janigian |
| Address | 120 Dudley Street |
| City | Providence |
| State | RI |
| ZIP | 02905 |
| Taxonomy | Retina Specialist (Ophthalmology) Physician |
| NPI Enumerated | June 23, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $839.2K |
| Medicaid | $53.6K |
This provider’s billing footprint is heavily Medicare-weighted: total Medicare revenue is $839.2K compared with total Medicaid revenue of $53.6K, indicating Medicare dominates this practice’s payer mix and Medicaid represents a small share of lifetime public-payer revenue. The difference in scale suggests this clinician operates primarily in the Medicare market rather than serving a Medicaid-heavy panel.
Medicare revenue is concentrated in intravitreal biologic therapy and related procedures — the precomputed top three Medicare codes (J0178, J2777, 67028) account for 83.4% of this provider's total Medicare revenue. J0178 (injection, aflibercept) alone represents $462.3K or 55.1% of Medicare revenue, and J2777 (injection, faricimab) contributes $179.2K (21.4%), signaling a practice organized around high-volume anti-VEGF and novel retinal injection services.
The Medicaid revenue profile is similarly concentrated: the precomputed top three Medicaid codes (99214, 92134, 67028) account for 95.4% of this provider's total Medicaid revenue. Medicaid revenue is led by E/M visits 99214 at $28.2K (52.8%) and retinal imaging 92134 at $15.8K (29.6%), with 67028 contributing $7K (13.0%), which implies that for Medicaid patients this clinician delivers a mix of office-based management and retina injections but at much lower overall scale than Medicare.
Competitive standing for the provider’s leading Medicare injection codes is modest nationally: J0178 ranks #1663 of 3204 (48th percentile), a mid-tier national presence for aflibercept injections, and J2777 ranks #1370 of 2039 (33th percentile), indicating lower relative volume for faricimab compared with peers. The ranking profile suggests the provider is an active injector in their local market but not a high-volume national outlier for these biologic agents.
Imaging and E/M services show different competitive signals across payers: Medicare 92134 (OCT imaging) generates $40.7K and ranks #1777 of 26868 (93th percentile) nationally, indicating comparatively high imaging volume among peers, while Medicare office E/M 99214 generates $46.1K and sits at #52221 of 479517 (89th percentile), reflecting strong use of higher-complexity office visits relative to the broad physician population. On the Medicaid side, 92134 ranks #9 of 24 in-state (65th percentile) and 99214 ranks #597 of 1731 in-state (65th percentile), which positions the provider as a typical to above-typical performer locally on these services but still much smaller in absolute Medicaid revenue.
Tenure on file is long: the NPI was enumerated 2005-06-23 (~21 years ago), which supports an assessment of sustained practice presence and likely established referral patterns in the Providence market. This duration of enrollment aligns with the observed concentrated service mix around retina injections and imaging.
Across multiple codes the data’s statistical descriptors consistently label volume as “typical, unremarkable volume for this code”: that plain-English characterization is applied to the provider’s J0178, J2777, 67028, 92134, and major E/M codes in the source lines. In other words, while certain services (for example Medicare 92134 imaging which sits in a high national percentile) are relatively prominent for this clinician, the reporting frames their volumes as within the expected range for peers rather than as extreme outliers.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
13 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 670 | $690 | $462.3K |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 6,180 | $30 | $179.2K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 600 | $100 | $57.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 480 | $100 | $46.1K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,270 | $30 | $40.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 310 | $70 | $21.4K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 80 | $130 | $10.2K |
| J9035 | Injection, bevacizumab, 10 mg | 150 | $50 | $7.9K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 70 | $100 | $6.7K |
| 92250 | Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,… | 130 | $30 | $3.7K |
Showing 1–10 of 13
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 13 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
13 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 7 | 10 | 670 | $690 | $601.6K |
| J2777 | 2 | 10 | 5,790 | $30 | $158K |
| 67028 | 9 | 20 | 610 | $90 | $58.9K |
| 92014 | 125 | 190 | 120 | $80 | $16.3K |
| 99214 | 81 | 1,950 | 100 | $80 | $11.7K |
| J9035 | 10 | 20 | 160 | $50 | $9.5K |
| 99213 | 197 | 1,950 | 70 | $60 | $7.4K |
| 92134 | 8 | 120 | 50 | $30 | $6.6K |
| 99204 | 72 | 740 | 30 | $110 | $4.6K |
| 92235 | 9 | 10 | 20 | $100 | $3.6K |
Showing 1–10 of 13
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
5 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 460 | $60 | $28.2K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 750 | $20 | $15.8K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 60 | $110 | $7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 50 | $40 | $2K |
| 92250 | Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,… | 10 | $30 | $440 |
How this provider's Medicaid billing volume and revenue compare to other Rhode Island providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Rhode Island median
5 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 11 | 10 | 170 | $230 | $144.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 597 | 1,730 | 220 | $70 | $75.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,607 | 2,050 | 300 | $50 | $72.3K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 9 | 20 | 560 | $50 | $61.6K |
| 92250 | Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,… | 70 | 80 | 140 | $30 | $16.9K |
Other providers in the same ZIP code as Robert Janigian, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.